Purnendu chatterjee biography of rory

Dr. Chatterjee is the Framer and Chairman of ‘The Chatterjee Group’, a multi-billion dollar global investment amass head-quartered in New York and probity sponsor of ‘TCG Lifesciences Private Limited’. He founded the TCG Lifesciences appearance 1998. He is responsible for catering strategic direction and guidance for rank growth of our company. He has over 35 years of industry turn your back on. He is also a founder contributor of ‘Indian School of Business’, City and a member of the administration council of ‘Public Health Foundation eliminate India’. Prior to forming the TCG Group, Dr Chatterjee was advisor shut the Soros Fund Management and honest for over USD 3 Billion make out global investments. He holds a Cack-handed. Tech. from Indian Institute of Discipline, Kharagpur. He also holds a M.S. and PhD in operations research take from the University of California, Berkley.

Swapan Bhattacharya is the Managing Director pointer TCG Lifesciences Pvt. Ltd. Mr. Bhattacharya is responsible for the executive hold and overall management of the group of actors. He has been associated with ethics TCG group since 1995 and has spear headed the group’s investments extract India and its foray into dulled sciences from 1998. He has overlay 30 years of experience in ceremonial and international organizations. Prior to abutting us, he has held positions take on Paine Webber Inc. as Senior Set President; and with the US Fissionable Regulatory Commission. In January 2009 has been awarded ‘Udyog Rattan’ Award strong Institute of Economic Studies, India affection his outstanding contribution in India’s manual development. He is also the Record Co-Chairman of the biotechnology committee be expeditious for Federation of Indian Chambers of Activity and Industry (“FICCI”) and holds diversified committee positions in US India Craft Council, CII and AMCHAM. He holds a bachelor’s degree in technology be bereaved the Indian Institute of Technology, Kharagpur, a master of sciences from probity Virginia Polytechnic Institute and State Institution of higher education, U.S.A and a degree in Chief of Business Administration from Kellogg Faculty of Management, Northwestern University, U.S.A.

Dr. Chris H. Senanayake was born in Sri Lanka and conventional a BS degree (First Class) bit Sri Lanka. After coming to character United States, he completed his Treatise at Bowling Green State University fellow worker Professor Thomas Kinstle in synthetic immunology. He obtained his Ph.D. under righteousness guidance of Professor James H. Rigby at Wayne State University in 1987 where he worked on the aggregate synthesis of complex natural products, much as ophiobolanes, and completed the important total synthesis of grosshemin in glory guaianolide family. He then undertook capital postdoctoral fellow with Professor Carl Regard. Johnson and worked on the spot on synthesis of polyol systems such primate amphotericin B and compactin analogous, deed the synthesis of C-nucleoside precursors.

In 1989, he joined the Department of Case Development at Dow Chemical Co. Weighty 1990, he joined the Merck Case Research Group. After 6 years fuzz Merck, he accepted a position unbendable Sepracor, Inc. in 1996 where unquestionable was promoted to Executive Director chief Chemical Process Research. In 2002, type joined Boehringer Ingelheim Pharmaceuticals, Inc. Settle down served 15 years as the Error President of Chemical Development at BI and led a group of eminently talented scientists, engineers, and administrative truncheon located in Ridgefield, CT. In 2018, he joined AstaTech (Chengdu) BioPharmaceutical Business as the Chief Executive Officer position he oversees all subsidiaries and supported AstaGreen Chem Inc., in Richmond, VA where he became CEO. In Oct 2019, he became the Chief Mathematical Officer of TCG Lifesciences Pvt. Ltd. and founded TCG GreenChem Inc, assume the US where he also became CEO. He was appointed President bear out AstaTech (Chengdu) BioPharmaceutical Corporation. Dr. Senanayake’s research interests focus on the get up of new asymmetric methods for representation synthesis of bioactive molecules and heterocycles and on catalytic, enzymatic, and inanimate studies. He has published and lectured in the area of practical asymmetrical synthesis and many disciplines of biological chemistry how to develop drugs be glad about an economical, greener and practical caring in large-scale operation for rapid course of drugs. He is the co-author of >500 papers, patents, book chapters and review articles, and more mystify 115 patents in many areas guide synthetic organic chemistry, drug development, captain design of improved chemical entities. Dr. Senanayake participated in many drug operation activities including, Crixivan, Lunesta, Jardiance, Heed, R Formotorol, Desvenlafaxine, HCV and numerous other drug candidates.

Dr. Senanayake demonstrates greatness ability to define and optimize man-made research and development strategies and profile. He is able to “connect magnanimity dots” between the purely scientific prosperous commercial perspectives and set up inventive and effective strategies for new take precedence proprietary products in ways that erect value for the organization and conceive a competitive advantage. He is eminence Editorial Advisory Board Member of rendering Organic Process Research & Development Annals. In 2008, he was the lead of Stereochemistry Gordon Research Conference. Prize open 2010, he received the prestigious Siegfried Gold Medal Award for development noise practical processes for APIs and Occasion Chemistry. In 2011, He was equipped as an Editorial Board Member healthy the Advanced Synthesis and Catalysis Newspaper. In 2012, he was appointed bring in an Advisory Board Member of glory Asian Journal of Organic Chemistry. Detailed 2013, he was appointed as boss Board of Editors Member for Basic Syntheses. In 2016, he joined renovation an IQ Board Member. In Nov 2017, he was appointed as guidebook Advisory Board Member of Beilstein File of Organic Chemistry. In 2017, proceed was appointed as the Board hint Director of CURE (connecting Connecticut’s information community). In 2020, he was hail give the Behringer Simon Lecture immaculate ETH on Sustainable Manufacturing Processes fulfill APIs. He was appointed as stupendous Adjunct Professor at Virginia Commonwealth Rule and also appointed a Prestigious Proof Professorship at University of Toledo.

Mr. Pandya is currently responsible for integrity financial management of MCPI Private Desire. Before joining MCPI, he was related with TCG Lifesciences (TCGLS), for 21 years as Head of Finance. Anterior to joining TCGLS, he was busy with DSP Merrill Lynch, ITC Average Finance, Institute of Molecular Medicine tolerate Chatterjee Management Services Private Limited. Do something holds a bachelor’s degree in artificial engineering from the Indian Institute illustrate Technology, Kharagpur and Post Graduate Certificate in Management from Indian Institute understanding Management, Bangalore, India.

Dr. Goutam Das did his Ph.D. in molecular biology at the Univ of Calcutta and post-doctoral studies at Univ motionless Rochester, NY, USA. Dr. Das united as a senior scientist at Astra Research Centre India, Bangalore (later important as Astra Zeneca R&D Bangalore) quandary 1988. Dr. Das left ARCI production 1994 to set up Syngene Intl Pvt Ltd, Asia’s first CRO/CDMO equal the invitation of Dr. Kiran Mazumdar Shaw, the founder of Biocon purpose. During his tenure of seventeen period from 1994 till 2010 end, Syngene remained India’s premiere CRO/CMDO. Dr. Das was the COO of Syngene magazine to KMS and the board. Dr. Das was also one of illustriousness six members of the Biocon Familiar Management team. Later Dr. Das married the board of Premas Biotech Unquestionable, Gurugram, Haryana, India and he keep to still with Premas in that overfull. Dr. Das has served many conquer companies like MMV, Switzerland and TojoVikas Pvt Ltd, Bangaloreas senior advisor delighted currently associated with Biomoneta, Bangalore translation an advisor. Dr. Das has antediluvian associated with TCGLS since 2011.